Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

Objectives Contact breast injury (CBI) and exercise-induced breast pain (EIBP) are common in adult female contact sports; ...

MDE pitched lawmakers on providing funding for more literacy and math coaches, another round of teacher pay raises, and ...

The rise of AI in South-east Asia presents transformative opportunities and challenges for nations and workers. Read more at ...